Physician profile
Kenneth Phun
NPI 1801837927
$2,038.67
in general payments reported to CMS, 2019-2025
12 companies · $93.20 in 2025
The $93.20 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $277 · 2021: $318 · 2022: $560 · 2023: $422 · 2024: $38.12 · 2025: $93.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $553.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $456.60 | 2021-2024 | Aristada, Lybalvi |
| Allergan, INC. | $318.11 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $266.06 | 2022-2023 | Fanapt, Hetlioz |
| Abbvie INC. | $229.95 | 2021-2025 | |
| Lundbeck LLC | $173.45 | 2019-2023 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $169.00 | 2019-2023 | Rexulti, Abilify Maintena |
| Teva Pharmaceuticals USA, INC. | $139.80 | 2019-2023 | Austedo Xr, Austedo |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $112.78 | 2021-2024 | Caplyta |
| Sunovion Pharmaceuticals INC. | $78.62 | 2021 | |
| Janssen Pharmaceuticals, INC | $49.48 | 2019-2023 | Invega Sustenna |
| E.R. Squibb & Sons, L.L.C. | $25.40 | 2025 | Cobenfy |
| Neurocrine Biosciences, INC. | $19.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Phun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.